Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1965-11-27
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0069-0112
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
83-6
|
pubmed:dateRevised |
2008-2-20
|
pubmed:meshHeading |
pubmed-meshheading:5829431-Adult,
pubmed-meshheading:5829431-Aged,
pubmed-meshheading:5829431-Animals,
pubmed-meshheading:5829431-Antineoplastic Agents,
pubmed-meshheading:5829431-Dogs,
pubmed-meshheading:5829431-Humans,
pubmed-meshheading:5829431-Mice,
pubmed-meshheading:5829431-Middle Aged,
pubmed-meshheading:5829431-Rats
|
pubmed:year |
1965
|
pubmed:articleTitle |
Phase I studies with thiocarzolamide (NSC-45409).
|
pubmed:publicationType |
Journal Article
|